National Liver Institute, Egypt

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Not Applicable

Recruiting

Conditions: Granulocyte Colony-stimulating Factor
Biliary Atresia

Interventions: Drug: Granulocyte Colony-Stimulating Factor

First Posted Date: 2024-11-27

Last Posted Date: 2024-12-11

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 40

Registration Number: NCT06708572

Locations: 🇪🇬
National Liver Institute, Cairo, Menofia Governorate, Egypt

Proton Pump Inhibitors in Cirrhotic Patients

Completed

Conditions: Proton Pump Inhibitor Adverse Reaction
Liver Cirrhosis

First Posted Date: 2024-04-25

Last Posted Date: 2024-04-25

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 1000

Registration Number: NCT06384443

Locations: 🇪🇬
National Liver institute - Menoufia University, Shibīn Al Kawm, Menoufia, Egypt

Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia

Phase 3

Completed

Conditions: Neonatal Jaundice

Interventions: Drug: Oral zinc sulfate and standard phototherapy

First Posted Date: 2024-01-29

Last Posted Date: 2024-01-29

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 192

Registration Number: NCT06227624

Locations: 🇪🇬
National Liver Institute, Shibīn Al Kawm, Menoufia, Egypt

Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Phase 4

Conditions: Helicobacter Pylori

Interventions: Drug: Naïve patients - ACO therapy
Drug: Naïve patients - LNDL therapy
Drug: Naïve patients - MNDL therapy
Drug: Treatment-experienced patients- LNDL therapy
Drug: Treatment-experienced patients- MNDL therapy

First Posted Date: 2022-01-11

Last Posted Date: 2022-01-11

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 500

Registration Number: NCT05184491

Locations: 🇪🇬
National Liver institute - Menoufia University, Shibīn Al Kawm, Menoufia, Egypt

Ultrasonography for Nutritional Assesment in Cirrhotic Patients

Conditions: Nutrition Assessment

First Posted Date: 2019-09-23

Last Posted Date: 2020-08-21

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 72

Registration Number: NCT04099875

Locations: 🇪🇬
National Liver Institute, Shibīn Al Kawm, Menoufia, Egypt

Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders

Not Applicable

Conditions: Progressive Familial Intrahepatic Cholestasis

Interventions: Device: Gastostomy-biliary tube
Device: External biliary diversion, internal biliary diversion and nasobiliary tube

First Posted Date: 2019-08-28

Last Posted Date: 2020-08-24

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 20

Registration Number: NCT04071197

Locations: 🇪🇬
Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Shibīn Al Kawm, Menofiya, Egypt

Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children

Not Applicable

Conditions: Children, Only
Refractory Ascites

Interventions: Drug: Midodrine 2.5 mg tab

First Posted Date: 2019-08-02

Last Posted Date: 2020-08-24

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 20

Registration Number: NCT04043858

Locations: 🇪🇬
Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Shibīn Al Kawm, Menofiya, Egypt

Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years

Not Applicable

Completed

Conditions: Hepatitis C, Chronic
Children, Only

Interventions: Drug: Sofosbovir/Lepipasvir (200/45mg) tablet (Heterosofir)

First Posted Date: 2018-12-05

Last Posted Date: 2019-09-17

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 30

Registration Number: NCT03764345

Locations: 🇪🇬
Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Shebin El-Koom, Menofiya, Egypt

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Phase 2

Conditions: Pharmacological Action

Interventions: Drug: Sofosbuvir Oral Product
Drug: Ribavirin

First Posted Date: 2016-12-07

Last Posted Date: 2016-12-19

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 41

Registration Number: NCT02985281

Locations: 🇪🇬
National liver institute, Segin el Kom, Menofia, Egypt

Steroids in Fulminant Hepatitis A in the Pediatric Age Group

Phase 4

Completed

Conditions: Fulminant Hepatic Failure

Interventions: Drug: prednisolone
Drug: methylprednisolone

First Posted Date: 2015-03-03

Last Posted Date: 2018-12-17

Lead Sponsor: National Liver Institute, Egypt

Target Recruit Count: 33

Registration Number: NCT02375867

Locations: 🇪🇬
National Liver Institute, Menoufia, Egypt

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy